Login / Signup

Inconsistencies in laboratory investigations of hypertension in a young woman taking ethinylestradiol/drospirenone association.

Patrice DufourLaurent VroonenCavalier EtienneCaroline Le Goff
Published in: Acta clinica Belgica (2022)
Considering the data in the literature and our clinical case, we suggest adding drospirenone and the ethinylestradiol/drospirenone association in the list of drugs interfering with aldosterone and renin level determination.
Keyphrases
  • blood pressure
  • systematic review
  • electronic health record
  • big data
  • machine learning
  • angiotensin ii
  • high resolution
  • mass spectrometry
  • deep learning